Amarin Corp Plcuk AMRN
NASDAQ AMRN
$14.09 +0.03 (+0.21%)
At close: Aug 21, 2026 · 4:00 PM EDT

Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020)

Amarin Corp Plc\Uk (AMRN) posted quarterly Amortization of Deferred Charges of $34000.0 for Q4 2020, down 90.61% year-over-year from $362000.0 in Q1 2020, and down 69.37% quarter-over-quarter from $111000.0 in Q3 2020.

Amarin Corp Plcuk (AMRN) Amortization of Deferred Charges (2012 - 2020) Analysis & Trends

Amarin Corp Plc\Uk (AMRN) has reported Amortization of Deferred Charges for 9 consecutive years, with $34000.0 the latest figure, recorded in Q4 2020.

  • In Q4 2020, Amortization of Deferred Charges fell 90.61% year-over-year to $34000.0; the TTM figure through Dec 2020 stood at $635000.0 (down 61.37% YoY), while the FY2020 annual figure was $635000.0, down 61.37% from the prior year.
  • Amortization of Deferred Charges fell to $34000.0 in Q4 2020 per AMRN's latest filing, from $111000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $2.6 million in Q2 2016 and bottomed at $34000.0 in Q4 2020.
  • Historically, Amortization of Deferred Charges has averaged $728850.0 across 5 years, with a median of $542000.0 in 2016.
  • Annual changes were most pronounced in 2016 — Amortization of Deferred Charges soared 36.65% — and 2020, when it sank 90.61%.
  • Amarin Corp Plc\Uk's Amortization of Deferred Charges stood at $537000.0 in 2016, then climbed by 10.99% to $596000.0 in 2017, then retreated by 16.78% to $496000.0 in 2018, then decreased by 27.02% to $362000.0 in 2019, then tumbled by 90.61% to $34000.0 in 2020.
  • Business Quant data shows AMRN's Amortization of Deferred Charges at $34000.0 in Q4 2020, $111000.0 in Q3 2020, and $201000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 652.20 Bn 631.44 Bn 17.26 Bn
2 AbbVie 469.51 Bn 462.94 Bn 12.70 Bn
3 Merck 376.81 Bn 369.67 Bn 12.21 Bn
4 Novartis Ag 303.04 Bn 295.35 Bn 11.24 Bn
5 Astrazeneca 257.61 Bn 252.71 Bn 12.86 Bn
6 Amgen 237.37 Bn 223.38 Bn 7.24 Bn
7 Gilead Sciences 181.73 Bn 178.55 Bn 6.22 Bn
8 Pfizer 159.66 Bn 147.96 Bn 10.94 Bn
9 Gsk 106.24 Bn 102.07 Bn 8.24 Bn
10 Amarin Corp Plcuk 5.86 Bn 5.54 Bn 14.99 Mn

Historic Data

Download Data
DateValue
Dec 31, 2020 34,000.00
Dec 31, 2020 34,000.00
Sep 30, 2020 111,000.00
Sep 30, 2020 111,000.00
Jun 30, 2020 201,000.00
Jun 30, 2020 201,000.00
Mar 31, 2020 289,000.00
Mar 31, 2020 289,000.00
Dec 31, 2019 362,000.00
Dec 31, 2019 362,000.00
Sep 30, 2019 404,000.00
Sep 30, 2019 404,000.00
Jun 30, 2019 432,000.00
Jun 30, 2019 432,000.00
Mar 31, 2019 446,000.00
Mar 31, 2019 446,000.00
Dec 31, 2018 496,000.00
Dec 31, 2018 496,000.00
Sep 30, 2018 547,000.00
Sep 30, 2018 547,000.00